One shot, two shots to covid safety?

Rebecca Stevenson
Fri, 05 Feb 2021

Rebecca Stevenson
Fri, 05 Feb 2021
The UK is set to trial combining two vaccines, from Pfizer and AstraZeneca, in a two-shot regime to combat the coronavirus.The trial will look at the immune responses after administering the Pfizer and AstraZeneca vaccines as either a primary vaccine, or a booster shot, at intervals of four and 12 weeks.Both vaccines are currently being used in the UK.A survey released this year into attitudes towards vaccination found most people in Britain - 78 percent - were the most willing to be vaccinated against covid-19. The study surveyed 13,500 people...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets analysis
KiwiSaver: The cost of being too conservative
Andy Fyers | Wed, 23 Jun 2021

A seemingly sensible decision to hold default KiwiSaver in low-risk funds, proved to be a costly one.

Regulation shortfall as platforms hit high times
David Chaplin | Wed, 23 Jun 2021

New Zealand investors are getting very comfortable using new, 'micro-investing' platforms, making gaps in their regulation important to address.

NZ may not feel full covid economic impact for 2, 3 years
Jenny Ruth | Wed, 23 Jun 2021

Banks hadn't accounted for unprecedented government economic support when they estimated likely covid losses early into the crisis.

Partner Content
Business events are increasingly important for corporates

Working from home is great, but there's real value in face-to-face connections.

Centuria provides new opportunities for industrial property investors

Centuria Capital is embarking on its second capital raising since merging with Augusta Capital in 2020.